Paraskeva E et al. (1999), CRM1-mediated recycling of snurportin 1 to the ...

XB-ART-13150

J Cell Biol 1999 Apr 19;1452:255-64.

Show Gene links Show Anatomy links

CRM1-mediated recycling of snurportin 1 to the cytoplasm.

Paraskeva E , Izaurralde E , Bischoff FR , Huber J , Kutay U , Hartmann E , Lührmann R , Görlich D .

???displayArticle.abstract???
Importin beta is a major mediator of import into the cell nucleus. Importin beta binds cargo molecules either directly or via two types of adapter molecules, importin alpha, for import of proteins with a classical nuclear localization signal (NLS), or snurportin 1, for import of m3G-capped U snRNPs. Both adapters have an NH2-terminal importin beta-binding domain for binding to, and import by, importin beta, and both need to be returned to the cytoplasm after having delivered their cargoes to the nucleus. We have shown previously that CAS mediates export of importin alpha. Here we show that snurportin 1 is exported by CRM1, the receptor for leucine-rich nuclear export signals (NESs). However, the interaction of CRM1 with snurportin 1 differs from that with previously characterized NESs. First, CRM1 binds snurportin 1 50-fold stronger than the Rev protein and 5,000-fold stronger than the minimum Rev activation domain. Second, snurportin 1 interacts with CRM1 not through a short peptide but rather via a large domain that allows regulation of affinity. Strikingly, snurportin 1 has a low affinity for CRM1 when bound to its m3G-capped import substrate, and a high affinity when substrate-free. This mechanism appears crucial for productive import cycles as it can ensure that CRM1 only exports snurportin 1 that has already released its import substrate in the nucleus.

???displayArticle.pubmedLink??? 10209022
???displayArticle.pmcLink??? PMC2133107

Species referenced: Xenopus laevis
Genes referenced: kpnb1 mmut mt-tr ran snupn trna xpo1

???attribute.lit??? ???displayArticles.show???

	Figure 2. Snurportin 1 interacts directly with CRM1 and importin Î² in a RanGTP-regulated manner. (A) Immobilized snurportin 1 was used to bind recombinant CRM1 from a total E. coli lysate. Where indicated, 1.3 Î¼M RanQ69L (GTP) was also added. Starting material and bound fractions were analyzed by SDS-PAGE followed by Coomassie staining. The load in the bound fractions corresponded to 20 times the starting material. (B) Immobilized RanQ69L was incubated with total E. coli lysates expressing either recombinant CRM1 (lanes 1 and 2), importin Î² (lanes 3 and 4), or a control lysate (lane 5). Where indicated, (+) 300 Î¼l of total E. coli lysate expressing a GST-snurportin 1 fusion protein was also included (lanes 1, 3, and 5). The interaction between snurportin 1 and CRM1 in the presence of RanQ69L is direct and a trimeric snurportin/CRM1/RanQ69L complex is formed.
	Figure 3. Kinetic characterization of the snurportin/CRM1/ RanGTP interaction. (A) The kinetic assay to measure complex formation is based on the observation that binding of RanGTP to an importin Î²âlike factor prevents GTPase activation by RanGAP. 50 pM Ran-[Î³-32P]GTP was preincubated at 15Â°C with the indicated concentrations of CRM1 in the absence or presence of 2 Î¼M snurportin 1 or 2 Î¼M importin Î± (human Rch1p). After 30 min, a 30-s GTPase reaction was started by addition of 40 nM Rna1p, the S. pombe RanGAP. Hydrolysis of Ran-bound GTP was determined as released [32P]phosphate. Note that Ran and snurportin 1 bound to CRM1 in a highly cooperative manner, with snurportin 1 increasing the apparent affinity of CRM1 for RanGTP roughly 1,000-fold. The apparent constant for dissociation of RanGTP from the trimeric complex is 4â5 nM. The presence of 15 nM RanBP1 relieved the GAP resistance of the complex completely. (B) Measurements were performed exactly as in A except that CAS was added instead of CRM1. Note that snurportin 1 bound selectively to CRM1, but not to CAS, while importin Î± bound to CAS but not to CRM1.
	Figure 4. CRM1 promotes the export of snurportin 1 from the nucleus. Nuclear import of 1.6 Î¼M fluorescein-labeled snurportin 1 and 1.6 Î¼M Texas redâlabeled importin Î± was allowed for 10 min in the presence of importin Î² (0.7 Î¼M) and nucleoplasmin (1.4 Î¼M) as described in Materials and Methods. After 10 min, one aliquot of the sample was fixed. The remaining sample was split in three. Either 3 Î¼M CRM1, 3 Î¼M CAS, or buffer was added and the incubation was continued for another 10 min before fixation. Nuclei were spun onto coverslips and fluorescent proteins were detected by confocal microscopy (63Ã oil objective). Note that addition of CRM1 specifically leads to a depletion of the intranuclear snurportin 1 and the appearance of an NPC staining, but had no effect on importin Î± distribution. In contrast, CAS promoted export of importin Î±, but not of snurportin.
	Figure 5. Binding of m3G-cap and of CRM1 to snurportin 1 are mutually exclusive. (A) Immobilized snurportin 1 was used to bind recombinant CRM1 out of total E. coli lysate either in the presence (lanes 3 and 5) or absence (lanes 2 and 4) of a 10-fold molar excess of a m3G-cap oligonucleotide (5 Î¼M). Where indicated, 11 Î¼M RanQ69L was also added (lanes 4 and 5). In the absence of Ran-GTP, m3G-cap prevented binding of CRM1 to snurportin, while in the presence of Ran-GTP binding of CRM1 to snurportin 1 is reduced but not abolished by m3G-cap. (B) Formation of the trimeric snurportin/CRM1/ RanGTP complex was measured as in Fig. 2 A, with the modification that the concentration of CRM1 was kept constant at 300 nM and the concentration of snurportin 1 was varied. Where indicated, snurportin 1 had been preincubated with either 5 Î¼M m3G-capped oligonucleotide or m7GpppG dinucleotide. Note that the m3G-cap RNA oligonucleotide specifically inhibited trimeric complex formation, while the m7G-cap analogue had no effect. (C) Measurements were performed exactly as in B except that a Rev-NES-BSA conjugate was used instead of snurportin. Note that the m3G-cap RNA oligonucleotide had no effect on the Rev-NES/CRM1/RanGTP interaction. (D) Measurements were performed exactly as in B, varying the concentrations of the following export substrates: snurportin 1; HIV Rev protein; Rev-NES peptide 1, which is a synthetic peptide (cys-LPPLERLTL) corresponding to the minimum Rev activation domain, Rev-NES peptide 2, which is a slightly larger peptide (cys-PVPLQLPPLERLTLD) that also includes NH2- and COOH-terminally flanking residues, Mut. NES peptide (cys-LPPDLRLTL), which corresponds to a loss-of-function mutant of the activation domain, was used as a negative control.
	Figure 6. Binding properties of snurportin 1 deletion mutants. Immobilized full-length snurportin 1 (lanes 2 and 3) or deletion mutants (lanes 4â11) were tested for binding of (A) CRM1 and (B) importin Î² from total E. coli lysates. Where indicated, 1.5 Î¼M RanQ69L GTP had also been added. Analysis was as in Fig. 2. Note that deletion of the 26 NH2-terminal residues of snurportin 1 abolished binding to CRM1. Deletion of >74 residues from the COOH terminus of snurportin 1 also resulted in the loss of the CRM1 interaction. All fragments that contained the IBB domain (residues 25â65) bound importin Î².
	Figure 7. Effects of nuclear injection of snurportin 1 on RNA export. Xenopus laevis oocyte nuclei were coinjected with a mixture of 32P-labeled RNAs and, where indicated, with purified recombinant GST-snurportin 1 fusion protein at the concentrations indicated above the lanes. The mixture of RNAs consisted of DHFR mRNA, histone H4 mRNA, U1Î”Sm snRNA, U5Î”Sm snRNA, U6Î”ss snRNA, and human initiator methionyl tRNA. The Î”Sm U snRNAs lack the Sm binding site required for reimport into the nucleus. U6Î”ss does not leave the nucleus and is an internal control for nuclear integrity and proper nuclear injection. Synthesis of DHFR and histone H4 mRNA, and U1Î”Sm and U5Î”Sm, was primed with the m7GpppG-cap dinucleotide and synthesis of U6Î”ss was primed with Î³-mGTP. RNA samples from total oocytes (T) or cytoplasmic (C) and nuclear (N) fractions were collected immediately after injection in lanes 1â€“3 or 180 min after injection in lanes 4â€“15. RNAs were resolved on 8% acrylamide/7 M urea denaturing gels. Note that coinjection of snurportin 1 specifically competed export of U1 and U5 snRNA but had only a negligible effect on mRNA export.
	Figure 8. The snurportin 1 nucleocytoplasmic transport cycle. (1) In the cytoplasm, snurportin 1 binds m3G-capped U snRNAs and (2) is translocated by importin Î² into the nucleus. Translocation is terminated by direct binding of nuclear RanGTP to importin Î² (3), which results in the dissociation of importin Î² from snurportin. (4) Release of the m3G-capped U snRNA from snurportin 1 is prerequisite for (5) incorporation of snurportin 1 into a trimeric export complex with CRM1 and RanGTP. The trimeric complex is exported to the cytoplasm where (6) RanGTP is removed from CRM1 through the action of RanBP1 and RanGAP. (7) CRM1 is displaced from snurportin 1 by the next m3G-capped import substrate and a new transport cycle can proceed. Î² stands for importin Î², Snp for snurportin 1; Sm for the Sm core domain; and m3G for the m3G-cap import signal of U snRNPs.

References [+] :

Adam, Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors. 1990, Pubmed, Xenbase